Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease

Wempe, J B; Postma, D S; Breederveld, N; Kort, E; van der Mark, T W; Koëter, G H
August 1992
Thorax;Aug1992, Vol. 47 Issue 8, p616
Academic Journal
No abstract available.


Related Articles

  • Efficacy of Inhaled Fluticasone Plus Salmeterol in COPD. Miller, Karl E. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2239 

    Deals with the findings of a study on the efficacy of fluticasone propionate and salmeterol in patients with chronic obstructive pulmonary disease (COPD). Use of bronchodilators as first-line therapy treatment for COPD; Effect of inhaled corticosteroids in patients with COPD; Effectiveness of...

  • Steroids in bronchitis.  // British Medical Journal;10/25/1980, Vol. 281 Issue 6248, p1088 

    Investigates the effect of methylprednisolone on chronic obstructive airways disease in Great Britain. Relevance of corticosteroid in the treatment of bronchial asthma; Suppression of the inflammatory response; Reversibility of airways obstruction with bronchodilators.

  • ABC of chronic obstructive pulmonary disease. Currie, Graeme P.; Lipworth, Brian J. // BMJ: British Medical Journal (International Edition);6/17/2006, Vol. 332 Issue 7555, p1439 

    The article presents information on inhaled treatment for patients with chronic obstructive airways disease (COPD). According to the article, all patients with COPD should be prescribed a short acting bronchodilator. The article discusses long acting bronchodilators, inhaled corticosteroids,...

  • Rethinking bioequivalence and equivalence requirements of orally inhaled drug products. Al-Numani, Dina; Colucci, Philippe; Ducharme, Murray P. // Asian Journal of Pharmaceutical Sciences;2015, Vol. 10 Issue 6, p461 

    Orally inhaled drug products (OIPs), such as corticosteroids and bronchodilators, are at the forefront of asthma and chronic obstructive pulmonary disease treatments, two diseases that afflict worldwide populations. Introducing generics of these products is essential, as the pricing of these...

  • Bronchodilators can be effective in reducing COPD symptoms. Zablocki, Elaine // Managed Healthcare Executive;Feb2008, Vol. 18 Issue 2, p42 

    The article focuses on the efficacy of bronchodilators for chronic obstructive pulmonary disease (COPD) mitigation. It discusses the usability of the long-acting and short acting bronchodilators in alleviating and mitigating the air-flow obstruction within the lungs. In addition, these...

  • A review of bronchodilators for chronic obstructive pulmonary disease. Smith, Haley // South African Pharmaceutical Journal;2013, Vol. 80 Issue 7, p9 

    Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that is associated with airway obstruction. COPD is a major cause of chronic morbidity and mortality throughout the world. It is a progressive condition, but is partially reversible through treatment, especially when...

  • New anti-inflammatory targets for chronic obstructive pulmonary disease. Barnes, Peter J. // Nature Reviews Drug Discovery;Jul2013, Vol. 12 Issue 7, p543 

    Chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation of the peripheral airways and lung parenchyma, which leads to progressive obstruction of the airways. Current management with long-acting bronchodilators does not reduce disease progression, and there are no...

  • Future treatments. Barnes, Peter J. // BMJ: British Medical Journal (International Edition);7/29/2006, Vol. 333 Issue 7561, p246 

    The article discusses the treatment of chronic obstructive pulmonary disease (COPD). Challenges in developing more effective drug therapies for the treatment of COPD are discussed. Current drug therapy for COPD is described, including long acting bronchodilators and inhaled corticosteroids....

  • Respiratory remedy. R.M.D. // Cortlandt Forum;11/25/96, Vol. 9 Issue 11, p66 

    Features the use of various bronchodilators for the treatment of obstructive pulmonary diseases. Ratio of drugs to be used; Concern on the effects of atropine on the lungs.

  • pirbuterol.  // Davis's Drug Guide for Nurses, 9th edition;2005, p856 

    Provides information on the bronchodilator and adrenergic agent pirbuterol. Use of the drug for the management of reversible airway disease due to asthma or chronic obstructive pulmonary disease; Actions and adverse side effects of the drug; Administration of the drug.


Read the Article


Sign out of this library

Other Topics